Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis

Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis

Francesco Manfredonia1, Livia Pasquali1, Angela Dardano2, Alfonso Iudice1, Luigi Murri1, Fabio Monzani21Department of Neuroscience and 2Department of Internal Medicine, University of Pisa, Pisa, ItalyAbstract: Interferon (INF) β 1a 22 or 44 µg (Rebif®) administ...

Full description

Bibliographic Details
Main Authors: Francesco Manfredonia, Livia Pasquali, Angela Dardano, Alfonso Iudice, Luigi Murri, Fabio Monzani
Format: Article
Language:English
Published: Dove Medical Press 2008-04-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/review-of-the-clinical-evidence-for-interferon-beta-1a-rebifsupregsup--a1021

Internet

http://www.dovepress.com/review-of-the-clinical-evidence-for-interferon-beta-1a-rebifsupregsup--a1021

Similar Items